Unaudited Quarterly Financial Information - Revised Condensed Consolidated Statements of Cash Flows (Details) - USD ($)
$ in Thousands |
3 Months Ended |
12 Months Ended |
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
| Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
| Net loss |
$ (28,304)
|
$ (18,615)
|
$ (25,686)
|
$ (13,801)
|
$ 4,788
|
$ 20,807
|
$ (22,977)
|
$ (13,506)
|
$ (86,406)
|
$ (10,888)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
|
|
| Depreciation and amortization |
|
|
|
1,086
|
|
|
|
452
|
5,465
|
2,895
|
| Write-off of inventory |
|
|
|
324
|
|
|
|
|
1,582
|
2,132
|
| Adjustment to property and equipment for sales type leases |
|
|
|
(625)
|
|
|
|
|
|
(91)
|
| Loss from impairment of property and equipment |
|
|
|
96
|
|
|
|
|
1,161
|
1,869
|
| Stock-based compensation |
|
|
|
3,927
|
|
|
|
309
|
22,498
|
9,596
|
| Non-cash interest expense |
|
|
|
5
|
|
|
|
2,344
|
55
|
5,245
|
| Non-cash lease expense |
|
|
|
197
|
|
|
|
|
811
|
0
|
| Change in fair value of derivative liability |
|
|
|
|
|
|
|
1,425
|
0
|
1,745
|
| Change in fair value of common stock warrant liability |
|
|
|
|
|
|
|
736
|
0
|
879
|
| Change in fair value of contingent earn-out liability |
|
|
|
(3,078)
|
|
|
|
|
(6,988)
|
(47,360)
|
| Change in fair value of contingently issuable common stock liability |
|
|
|
(1,472)
|
|
|
|
|
(1,872)
|
(6,406)
|
| Change in fair value of public warrant liability |
|
|
|
(5,586)
|
|
|
|
|
(4,906)
|
(12,606)
|
| Changes in operating assets and liabilities |
|
|
|
|
|
|
|
|
|
|
| Accounts receivable |
|
|
|
(2,112)
|
|
|
|
(874)
|
(25,593)
|
(5,063)
|
| Inventory |
|
|
|
(1,310)
|
|
|
|
(480)
|
(8,495)
|
(3,436)
|
| Commission assets |
|
|
|
(351)
|
|
|
|
(391)
|
(3,675)
|
(3,072)
|
| Contract assets |
|
|
|
108
|
|
|
|
(119)
|
639
|
(4,877)
|
| Other assets |
|
|
|
141
|
|
|
|
7
|
(419)
|
32
|
| Prepaid expenses and other current assets |
|
|
|
(5,571)
|
|
|
|
(3,727)
|
(3,174)
|
(9,148)
|
| Accounts payable |
|
|
|
(855)
|
|
|
|
959
|
7,661
|
765
|
| Deferred revenue |
|
|
|
2,577
|
|
|
|
(806)
|
26,887
|
4,832
|
| Deferred rent |
|
|
|
0
|
|
|
|
(11)
|
0
|
457
|
| Accrued expenses and other current liabilities |
|
|
|
|
|
|
|
1,306
|
|
2,472
|
| Accrued expenses and other current liabilities |
|
|
|
(2,433)
|
|
|
|
|
1,462
|
2,472
|
| Operating lease liability |
|
|
|
(697)
|
|
|
|
|
(946)
|
0
|
| Net cash used in operating activities |
|
|
|
(29,430)
|
|
|
|
(12,439)
|
(74,728)
|
(56,781)
|
| Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
| Development of internal-use software |
|
|
|
(728)
|
|
|
|
|
(2,720)
|
(1,028)
|
| Purchases of property and equipment |
|
|
|
(6,689)
|
|
|
|
(2,121)
|
(21,473)
|
(16,557)
|
| Net cash used in investing activities |
|
|
|
(7,417)
|
|
|
|
(2,121)
|
(23,881)
|
(17,585)
|
| Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of stock options |
|
|
|
227
|
|
|
|
455
|
827
|
915
|
| Repayment of financing obligations |
|
|
|
|
|
|
|
(359)
|
0
|
(359)
|
| Proceeds from long-term debt, net of issuance costs |
|
|
|
|
|
|
|
31,882
|
29,683
|
31,882
|
| Net cash provided by (used in) financing activities |
|
|
|
227
|
|
|
|
31,978
|
20,510
|
377,829
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
|
(36,620)
|
|
|
|
17,418
|
(78,109)
|
303,463
|
| Cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
|
|
| Cash, cash equivalents and restricted cash at beginning of period |
|
|
271,547
|
308,167
|
|
|
22,122
|
4,704
|
308,167
|
4,704
|
| Cash, cash equivalents and restricted cash at end of period |
$ 230,058
|
|
|
271,547
|
308,167
|
|
|
22,122
|
230,058
|
308,167
|
| Supplemental disclosure of cash flow information |
|
|
|
|
|
|
|
|
|
|
| Transfer of inventory to property and equipment |
|
|
|
0
|
|
|
|
|
|
0
|
| Capital expenditures incurred but not yet paid |
|
|
|
2,391
|
|
|
|
1,335
|
7,552
|
2,936
|
| Issuance of equity classified warrants |
|
|
|
|
|
|
|
1
|
|
0
|
| As Previously Reported |
|
|
|
|
|
|
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
|
(14,551)
|
|
|
|
(13,755)
|
|
(10,858)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
|
|
| Depreciation and amortization |
|
|
|
948
|
|
|
|
452
|
|
2,895
|
| Write-off of inventory |
|
|
|
324
|
|
|
|
|
|
2,132
|
| Adjustment to property and equipment for sales type leases |
|
|
|
(321)
|
|
|
|
|
|
(91)
|
| Loss from impairment of property and equipment |
|
|
|
96
|
|
|
|
|
|
1,869
|
| Stock-based compensation |
|
|
|
5,190
|
|
|
|
1,082
|
|
8,511
|
| Non-cash interest expense |
|
|
|
5
|
|
|
|
2,344
|
|
5,245
|
| Non-cash lease expense |
|
|
|
197
|
|
|
|
|
|
|
| Change in fair value of derivative liability |
|
|
|
|
|
|
|
1,425
|
|
1,745
|
| Change in fair value of common stock warrant liability |
|
|
|
|
|
|
|
736
|
|
879
|
| Change in fair value of contingent earn-out liability |
|
|
|
(4,226)
|
|
|
|
|
|
(46,212)
|
| Change in fair value of contingently issuable common stock liability |
|
|
|
(1,472)
|
|
|
|
|
|
(6,406)
|
| Change in fair value of public warrant liability |
|
|
|
(5,586)
|
|
|
|
|
|
(12,606)
|
| Changes in operating assets and liabilities |
|
|
|
|
|
|
|
|
|
|
| Accounts receivable |
|
|
|
(2,112)
|
|
|
|
(874)
|
|
(5,063)
|
| Inventory |
|
|
|
(6,985)
|
|
|
|
(433)
|
|
(17,479)
|
| Commission assets |
|
|
|
(351)
|
|
|
|
(391)
|
|
(3,072)
|
| Contract assets |
|
|
|
108
|
|
|
|
(119)
|
|
(4,877)
|
| Other assets |
|
|
|
0
|
|
|
|
0
|
|
0
|
| Prepaid expenses and other current assets |
|
|
|
(5,280)
|
|
|
|
(4,104)
|
|
(10,079)
|
| Accounts payable |
|
|
|
(1,867)
|
|
|
|
1,194
|
|
(7)
|
| Deferred revenue |
|
|
|
2,778
|
|
|
|
(621)
|
|
4,968
|
| Deferred rent |
|
|
|
(468)
|
|
|
|
(11)
|
|
457
|
| Accrued expenses and other current liabilities |
|
|
|
|
|
|
|
1,100
|
|
5,174
|
| Accrued expenses and other current liabilities |
|
|
|
(2,065)
|
|
|
|
|
|
|
| Operating lease liability |
|
|
|
(229)
|
|
|
|
|
|
|
| Net cash used in operating activities |
|
|
|
(35,867)
|
|
|
|
(12,038)
|
|
(69,628)
|
| Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
| Development of internal-use software |
|
|
|
(646)
|
|
|
|
|
|
(1,028)
|
| Purchases of property and equipment |
|
|
|
(323)
|
|
|
|
(2,522)
|
|
(3,710)
|
| Net cash used in investing activities |
|
|
|
(969)
|
|
|
|
(2,522)
|
|
(4,738)
|
| Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of stock options |
|
|
|
216
|
|
|
|
455
|
|
915
|
| Repayment of financing obligations |
|
|
|
|
|
|
|
(359)
|
|
(359)
|
| Proceeds from long-term debt, net of issuance costs |
|
|
|
|
|
|
|
31,882
|
|
31,882
|
| Net cash provided by (used in) financing activities |
|
|
|
216
|
|
|
|
31,978
|
|
377,829
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
|
(36,620)
|
|
|
|
17,418
|
|
303,463
|
| Cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
|
|
| Cash, cash equivalents and restricted cash at beginning of period |
|
|
271,547
|
308,167
|
|
|
22,122
|
4,704
|
308,167
|
4,704
|
| Cash, cash equivalents and restricted cash at end of period |
|
|
|
271,547
|
308,167
|
|
|
22,122
|
|
308,167
|
| Supplemental disclosure of cash flow information |
|
|
|
|
|
|
|
|
|
|
| Transfer of inventory to property and equipment |
|
|
|
4,620
|
|
|
|
|
|
12,949
|
| Capital expenditures incurred but not yet paid |
|
|
|
1,693
|
|
|
|
0
|
|
347
|
| Issuance of equity classified warrants |
|
|
|
|
|
|
|
1
|
|
1
|
| Adjustment |
|
|
|
|
|
|
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
|
750
|
|
|
|
249
|
|
(30)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
|
|
| Depreciation and amortization |
|
|
|
138
|
|
|
|
0
|
|
0
|
| Write-off of inventory |
|
|
|
0
|
|
|
|
|
|
0
|
| Adjustment to property and equipment for sales type leases |
|
|
|
(304)
|
|
|
|
|
|
0
|
| Loss from impairment of property and equipment |
|
|
|
0
|
|
|
|
|
|
0
|
| Stock-based compensation |
|
|
|
(1,263)
|
|
|
|
(773)
|
|
1,085
|
| Non-cash interest expense |
|
|
|
0
|
|
|
|
0
|
|
0
|
| Non-cash lease expense |
|
|
|
0
|
|
|
|
|
|
|
| Change in fair value of derivative liability |
|
|
|
|
|
|
|
0
|
|
0
|
| Change in fair value of common stock warrant liability |
|
|
|
|
|
|
|
0
|
|
0
|
| Change in fair value of contingent earn-out liability |
|
|
|
1,148
|
|
|
|
|
|
(1,148)
|
| Change in fair value of contingently issuable common stock liability |
|
|
|
0
|
|
|
|
|
|
0
|
| Change in fair value of public warrant liability |
|
|
|
0
|
|
|
|
|
|
0
|
| Changes in operating assets and liabilities |
|
|
|
|
|
|
|
|
|
|
| Accounts receivable |
|
|
|
0
|
|
|
|
0
|
|
0
|
| Inventory |
|
|
|
5,675
|
|
|
|
(47)
|
|
14,043
|
| Commission assets |
|
|
|
0
|
|
|
|
0
|
|
0
|
| Contract assets |
|
|
|
0
|
|
|
|
0
|
|
0
|
| Other assets |
|
|
|
141
|
|
|
|
7
|
|
32
|
| Prepaid expenses and other current assets |
|
|
|
(291)
|
|
|
|
377
|
|
931
|
| Accounts payable |
|
|
|
1,012
|
|
|
|
(235)
|
|
772
|
| Deferred revenue |
|
|
|
(201)
|
|
|
|
(185)
|
|
(136)
|
| Deferred rent |
|
|
|
468
|
|
|
|
0
|
|
0
|
| Accrued expenses and other current liabilities |
|
|
|
|
|
|
|
206
|
|
(2,702)
|
| Accrued expenses and other current liabilities |
|
|
|
(368)
|
|
|
|
|
|
|
| Operating lease liability |
|
|
|
(468)
|
|
|
|
|
|
|
| Net cash used in operating activities |
|
|
|
6,437
|
|
|
|
(401)
|
|
12,847
|
| Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
| Development of internal-use software |
|
|
|
(82)
|
|
|
|
|
|
0
|
| Purchases of property and equipment |
|
|
|
(6,366)
|
|
|
|
401
|
|
(12,847)
|
| Net cash used in investing activities |
|
|
|
(6,448)
|
|
|
|
401
|
|
(12,847)
|
| Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of stock options |
|
|
|
11
|
|
|
|
0
|
|
0
|
| Repayment of financing obligations |
|
|
|
|
|
|
|
0
|
|
0
|
| Proceeds from long-term debt, net of issuance costs |
|
|
|
|
|
|
|
0
|
|
0
|
| Net cash provided by (used in) financing activities |
|
|
|
11
|
|
|
|
0
|
|
0
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
|
|
|
0
|
|
|
|
0
|
|
0
|
| Cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
|
|
| Cash, cash equivalents and restricted cash at beginning of period |
|
|
$ 0
|
0
|
|
|
$ 0
|
0
|
$ 0
|
0
|
| Cash, cash equivalents and restricted cash at end of period |
|
|
|
0
|
$ 0
|
|
|
0
|
|
0
|
| Supplemental disclosure of cash flow information |
|
|
|
|
|
|
|
|
|
|
| Transfer of inventory to property and equipment |
|
|
|
(4,620)
|
|
|
|
|
|
(12,949)
|
| Capital expenditures incurred but not yet paid |
|
|
|
$ 698
|
|
|
|
1,335
|
|
2,589
|
| Issuance of equity classified warrants |
|
|
|
|
|
|
|
$ 0
|
|
$ (1)
|